Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W E Wade

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 6, 2001
Cost comparison of tinzaparin versus enoxaparin as deep venous thrombosis prophylaxis in spinal cord injury: preliminary dataW E Wade, W J Spruill
Pharmacotherapy|March 1, 1995
Pharmacist-managed aminoglycoside therapy in combination with a beta-lactam agent in the treatment of nosocomial pneumonia in critically ill patientsW E Wade, C Y McCall
Thrombosis Research|April 23, 1999
Cost-effectiveness analysis of deep vein thrombosis prophylaxis in internal medicine patientsW E Wade, M A Chisholm
Hospital Formulary|October 1, 1990
Drug usage evaluation of aminoglycoside-induced nephrotoxicity in a community hospitalW E Wade, C Y McCall
American Journal of Orthopedics (Belle Mead, N.J.)|June 27, 2000
Cost effectiveness of deep venous thrombosis prophylaxis after hip fractureW E Wade, M A Chisholm
Pharmacotherapy|December 17, 1997
Cost analysis of the American College of Chest Physicians guidelines for deep vein thrombosis prophylaxis in patients undergoing orthopedic arthroplastic surgeryW E Wade, W J Spruill
American Journal of Hospital Pharmacy|November 1, 1993
Physician use of a pharmacist-managed parenteral nutritional support program over 10 yearsC Y McCall, W E Wade
Orthopedics|May 3, 2000
Cost effectiveness of outpatient anticoagulant prophylaxis after total hip arthroplastyW E Wade, D W Hawkins
Clinical Therapeutics|September 1, 1995
Pharmacoeconomic impact of a drug use evaluation of ceftriaxone in an acute-care medical centerW E Wade, C Y McCall
Therapeutic Drug Monitoring|January 1, 1990
Therapeutic drug monitoring in a community hospitalW E Wade, C Y McCall
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 6, 2001
Cost comparison of tinzaparin versus enoxaparin as deep venous thrombosis prophylaxis in spinal cord injury: preliminary dataW E Wade, W J Spruill
Pharmacotherapy|March 1, 1995
Pharmacist-managed aminoglycoside therapy in combination with a beta-lactam agent in the treatment of nosocomial pneumonia in critically ill patientsW E Wade, C Y McCall
Thrombosis Research|April 23, 1999
Cost-effectiveness analysis of deep vein thrombosis prophylaxis in internal medicine patientsW E Wade, M A Chisholm
Hospital Formulary|October 1, 1990
Drug usage evaluation of aminoglycoside-induced nephrotoxicity in a community hospitalW E Wade, C Y McCall
American Journal of Orthopedics (Belle Mead, N.J.)|June 27, 2000
Cost effectiveness of deep venous thrombosis prophylaxis after hip fractureW E Wade, M A Chisholm
Pharmacotherapy|December 17, 1997
Cost analysis of the American College of Chest Physicians guidelines for deep vein thrombosis prophylaxis in patients undergoing orthopedic arthroplastic surgeryW E Wade, W J Spruill
American Journal of Hospital Pharmacy|November 1, 1993
Physician use of a pharmacist-managed parenteral nutritional support program over 10 yearsC Y McCall, W E Wade
Orthopedics|May 3, 2000
Cost effectiveness of outpatient anticoagulant prophylaxis after total hip arthroplastyW E Wade, D W Hawkins
Clinical Therapeutics|September 1, 1995
Pharmacoeconomic impact of a drug use evaluation of ceftriaxone in an acute-care medical centerW E Wade, C Y McCall
Therapeutic Drug Monitoring|January 1, 1990
Therapeutic drug monitoring in a community hospitalW E Wade, C Y McCall
Pageof 4